Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study.

Wollenhaupt J, Lee EB, Curtis JR, Silverfield J, Terry K, Soma K, Mojcik C, DeMasi R, Strengholt S, Kwok K, Lazariciu I, Wang L, Cohen S.

Arthritis Res Ther. 2019 Apr 5;21(1):89. doi: 10.1186/s13075-019-1866-2.

2.

FV-100 versus valacyclovir for the prevention of post-herpetic neuralgia and the treatment of acute herpes zoster-associated pain: A randomized-controlled trial.

Tyring SK, Lee P, Hill GT Jr, Silverfield JC, Moore AY, Matkovits T, Sullivan-Bolyai J.

J Med Virol. 2017 Jul;89(7):1255-1264. doi: 10.1002/jmv.24750. Epub 2016 Dec 26.

3.

The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis.

Winthrop KL, Silverfield J, Racewicz A, Neal J, Lee EB, Hrycaj P, Gomez-Reino J, Soma K, Mebus C, Wilkinson B, Hodge J, Fan H, Wang T, Bingham CO 3rd.

Ann Rheum Dis. 2016 Apr;75(4):687-95. doi: 10.1136/annrheumdis-2014-207191. Epub 2015 Mar 20.

4.

Safety and efficacy of tofacitinib, an oral janus kinase inhibitor, for the treatment of rheumatoid arthritis in open-label, longterm extension studies.

Wollenhaupt J, Silverfield J, Lee EB, Curtis JR, Wood SP, Soma K, Nduaka CI, Benda B, Gruben D, Nakamura H, Komuro Y, Zwillich SH, Wang L, Riese RJ.

J Rheumatol. 2014 May;41(5):837-52. doi: 10.3899/jrheum.130683. Epub 2014 Apr 1.

5.

Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial.

Goldbach-Mansky R, Wilson M, Fleischmann R, Olsen N, Silverfield J, Kempf P, Kivitz A, Sherrer Y, Pucino F, Csako G, Costello R, Pham TH, Snyder C, van der Heijde D, Tao X, Wesley R, Lipsky PE.

Ann Intern Med. 2009 Aug 18;151(4):229-40, W49-51.

6.

Tramadol/acetaminophen combination tablets for the treatment of pain associated with osteoarthritis flare in an elderly patient population.

Rosenthal NR, Silverfield JC, Wu SC, Jordan D, Kamin M; CAPSS-105 Study Group.

J Am Geriatr Soc. 2004 Mar;52(3):374-80.

PMID:
14962151
8.

Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac.

Furst DE, Kolba KS, Fleischmann R, Silverfield J, Greenwald M, Roth S, Hall DB, Roszko PJ; Meloxicam Rheumatoid Arthritis Investigators.

J Rheumatol. 2002 Mar;29(3):436-46.

PMID:
11908554
9.

Tenidap in rheumatoid arthritis. A 24-week double-blind comparison with hydroxychloroquine-plus-piroxicam, and piroxicam alone.

Blackburn WD Jr, Prupas HM, Silverfield JC, Poiley JE, Caldwell JR, Collins RL, Miller MJ, Sikes DH, Kaplan H, Fleischmann R, et al.

Arthritis Rheum. 1995 Oct;38(10):1447-56.

PMID:
7575694
10.

Intra-articular orgotein in osteoarthritis of the knee: a placebo-controlled efficacy, safety, and dosage comparison.

McIlwain H, Silverfield JC, Cheatum DE, Poiley J, Taborn J, Ignaczak T, Multz CV.

Am J Med. 1989 Sep;87(3):295-300.

PMID:
2773967
11.

Rheumatoid vasculitis: survival and associated risk factors.

Vollertsen RS, Conn DL, Ballard DJ, Ilstrup DM, Kazmar RE, Silverfield JC.

Medicine (Baltimore). 1986 Nov;65(6):365-75.

PMID:
3784899
12.

T-lymphocyte subsets during pregnancy and the menstrual cycle.

Coulam CB, Silverfield JC, Kazmar RE, Fathman CG.

Am J Reprod Immunol. 1983 Sep;4(2):88-90.

PMID:
6228154
13.

Pseudogout masking other arthritides.

Zyskowski LP, Silverfield JC, O'Duffy JD.

J Rheumatol. 1983 Jun;10(3):449-53.

PMID:
6887168
14.

Immunochemical properties of human low density lipoproteins as explored by monoclonal antibodies. Binding characteristics distinct from those of conventional serum antibodies.

Mao SJ, Kazmar RE, Silverfield JC, Alley MC, Kluge K, Fathman CG.

Biochim Biophys Acta. 1982 Nov 12;713(2):365-74.

PMID:
6185154

Supplemental Content

Loading ...
Support Center